Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Interpace Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was $4.46M, down 11.8% year over year. For fiscal 2025 it was $5.83M, up 25.5% from the year before. The highest annual figure on record is $16.35M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.83M | +25.5% |
| FY2024 | Dec 31, 2024 | $4.65M | +22.6% |
| FY2023 | Dec 31, 2023 | $3.79M | – |
| FY2022 | Dec 31, 2022 | -$7.69M | – |
| FY2021 | Dec 31, 2021 | -$8.72M | – |
| FY2020 | Dec 31, 2020 | -$13.98M | – |
| FY2019 | Dec 31, 2019 | -$18.96M | – |
| FY2018 | Dec 31, 2018 | -$8.67M | – |
| FY2017 | Dec 31, 2017 | -$15.26M | – |
| FY2016 | Dec 31, 2016 | -$7.61M | – |
| FY2015 | Dec 31, 2015 | -$19.84M | – |
| FY2014 | Dec 31, 2014 | -$16.38M | – |
| FY2013 | Dec 31, 2013 | -$3.51M | – |
| FY2012 | Dec 31, 2012 | -$10.29M | -618.2% |
| FY2011 | Dec 31, 2011 | $1.99M | -87.9% |
| FY2010 | Dec 31, 2010 | $16.35M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $98.00K | -81.2% |
| Q1 FY2026 | Mar 31, 2026 | $283.00K | -77.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.14M | +80.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.94M | -8.4% |
| Q2 FY2025 | Jun 30, 2025 | $520.00K | -63.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.24M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.18M | +3.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.12M | +91.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.40M | +241.6% |
| Q1 FY2024 | Mar 31, 2024 | -$58.00K | -105.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.14M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.11M | – |
| Q2 FY2023 | Jun 30, 2023 | $411.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $1.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$276.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.24M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.92M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$676.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.82M | -505.1% |
| Q1 FY2021 | Mar 31, 2021 | -$5.01M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.58M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.72M | – |
| Q2 FY2020 | Jun 30, 2020 | $449.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.12M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.83M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.96M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.87M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.77M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.53M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.49M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.38M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.31M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.42M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.15M | – |
| Q4 FY2016 | Dec 31, 2016 | -$990.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.35M | – |
See a number that looks wrong?